Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Plutzky

Showing results (1-10 of 195) with videos related to

Pageof 20
Sort By:
Circulation Research|April 16, 2011
The PPAR-RXR transcriptional complex in the vasculature: energy in the balanceJorge Plutzky
Circulation. Cardiovascular Genetics|December 18, 2014
Emerging epigenetic maps in atherosclerosisJorge Plutzky
The American Journal of Medicine|December 18, 2003
The vascular biology of atherosclerosisJorge Plutzky
The American Journal of Cardiology|December 25, 2007
A cardiologist's perspective on cardiometabolic riskJorge Plutzky
The American Journal of Cardiology|August 2, 2011
Macrovascular effects and safety issues of therapies for type 2 diabetesJorge Plutzky
Postgraduate Medicine|August 12, 2009
Diabetes as a vascular disease. Dyslipidemia as a targetJorge Plutzky
Science (New York, N.Y.)|October 18, 2003
Medicine. PPARs as therapeutic targets: reverse cardiology?Jorge Plutzky
Journal of the American College of Cardiology|December 4, 2003
Peroxisome proliferator-activated receptors as therapeutic targets in inflammationJorge Plutzky
Reviews in Endocrine & Metabolic Disorders|June 24, 2004
Inflammation in atherosclerosis and diabetes mellitusJorge Plutzky
Clinical Cardiology|October 9, 2004
PPARs: altering clinical responses in Type 2 diabetes and atherosclerosis. IntroductionJorge Plutzky
Pageof 20

Showing results (1-10 of 195) with videos related to

Sort By:
Pageof 20
Circulation Research|April 16, 2011
The PPAR-RXR transcriptional complex in the vasculature: energy in the balanceJorge Plutzky
Circulation. Cardiovascular Genetics|December 18, 2014
Emerging epigenetic maps in atherosclerosisJorge Plutzky
The American Journal of Medicine|December 18, 2003
The vascular biology of atherosclerosisJorge Plutzky
The American Journal of Cardiology|December 25, 2007
A cardiologist's perspective on cardiometabolic riskJorge Plutzky
The American Journal of Cardiology|August 2, 2011
Macrovascular effects and safety issues of therapies for type 2 diabetesJorge Plutzky
Postgraduate Medicine|August 12, 2009
Diabetes as a vascular disease. Dyslipidemia as a targetJorge Plutzky
Science (New York, N.Y.)|October 18, 2003
Medicine. PPARs as therapeutic targets: reverse cardiology?Jorge Plutzky
Journal of the American College of Cardiology|December 4, 2003
Peroxisome proliferator-activated receptors as therapeutic targets in inflammationJorge Plutzky
Reviews in Endocrine & Metabolic Disorders|June 24, 2004
Inflammation in atherosclerosis and diabetes mellitusJorge Plutzky
Clinical Cardiology|October 9, 2004
PPARs: altering clinical responses in Type 2 diabetes and atherosclerosis. IntroductionJorge Plutzky
Pageof 20